Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype

被引:33
|
作者
Bhattacharyya, D
Brooks, BR
Callahan, L
机构
[1] NIH, DIV COMP RES & TECHNOL, STRUCT BIOL LAB, BETHESDA, MD 20892 USA
[2] US PHARMACOPEIAL CONVENT INC, ROCKVILLE, MD 20852 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PRINCIPAL NEUTRALIZING DETERMINANT; HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PHENOTYPE; DEXTRAN SULFATE; INFECTION; DOMAIN; GP120; PROGRESSION; CAPACITY;
D O I
10.1089/aid.1996.12.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the V3 loop of the envelope glycoprotein (gp120) plays a role in determining the phenotype, pathogenesis, and tropism of human immunodeficiency virus-1 (HIV-1), there has not been any consistent correlation between structure and phenotype, Theoretically determined structures of the V3 loop of gp120, from 20 different viral strains, 10 syncytium-inducing (SI) and 10 non-syncytium-inducing (NSI) phenotype, revealed that all V3 loops from SI phenotypic strains had at least two positively charged residues in close proximity, on the same face of the loop, All of the SI phenotypic V3 loop structures were capable of forming strong divalent electrostatic interactions with disulfated sugars. The ability to form this interaction may be a determinant of the phenotype, tropism, and pathogenicity of HIV-1 viral strains, This structural motif was absent in all V3 loops from viral strains with the NSI phenotype.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [41] Envelope diversity, Co-receptor usage, and syncytium-inducing phenotype of HIV-1 variants in oral fluids and blood during primary infection.
    Shugars, D. C.
    Freel, S. A.
    Fiscus, S. A.
    Pilcher, C. D.
    Lennox, J. L.
    Hicks, C. B.
    Eron, J. J., Jr.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B234 - B234
  • [42] Mutations within the CD4-CDR-3-like loop allow replication in an immortalized T cell line of HIV type 1 viruses chimeric for envelope glycoproteins containing non-syncytium-inducing V3 loops
    Signoret, N
    deJong, J
    Goudsmit, J
    Sattentau, QJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (02) : 121 - 123
  • [43] SEROTYPING HIV TYPE-1 BY ANTIBODY-BINDING TO THE V3 LOOP - RELATIONSHIP TO VIRAL GENOTYPE
    CHEINGSONGPOPOV, R
    LISTER, S
    CALLOW, D
    KALEEBU, P
    BEDDOWS, S
    WEBER, J
    OSMANOV, S
    BELSEY, EM
    HEYWARD, W
    ESPARZA, J
    GALVAOCASTRO, B
    VANDEPERRE, P
    KARITA, E
    WASI, C
    SEMPALA, S
    TUGUME, B
    BIRYAHWAHO, B
    RUBSAMENWAIGMANN, H
    VONBRIESEN, H
    ESSER, R
    GREZ, M
    HOLMES, H
    NEWBERRY, A
    RANJBAR, S
    TOMLINSON, P
    BRADAC, J
    MCCUTCHAN, F
    LOUWAGIE, J
    HEGERICH, P
    LOPEZGALINDEZ, C
    OLIVARES, I
    DOPAZO, J
    MULLINS, JI
    DELWART, EL
    BACHMANN, HM
    GOUDSMIT, J
    DEWOLF, F
    HAHN, BH
    GAO, F
    YUE, L
    SARAGOSTI, S
    SCHOCHETMAN, G
    KALISH, M
    LUO, CC
    GEORGE, R
    PAU, CP
    NARA, P
    FENYO, EM
    ALBERT, J
    MYERS, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) : 1379 - 1386
  • [44] Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells
    Su, J
    Palm, A
    Wu, YP
    Sandin, S
    Höglund, S
    Vahlne, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (01) : 37 - 48
  • [45] Structural Conservation Predominates Over Sequence Variability in the Crown of HIV Type 1's V3 Loop
    Almond, David
    Kimura, Tetsuya
    Kong, XiangPeng
    Swetnam, James
    Zolla-Pazner, Susan
    Cardozo, Timothy
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (06) : 717 - 723
  • [46] Mutations in the vpu, env, and nef genes of a syncytium-inducing variant of HIV type 1 JR-CSF that infects a range of T cell lines
    Klasse, PJ
    Boyd, MT
    Weiss, RA
    Schulz, TF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (04) : 347 - 350
  • [47] Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop
    Sato, H
    Kato, K
    Takebe, Y
    VIROLOGY, 1999, 257 (02) : 491 - 501
  • [48] Fine analysis of immunoreactivity of V3 peptides: Antibodies specific for V3 domain of laboratory HIV type 1 strains recognize multiple V3 sequences synthesized from field HIV type 1 isolates
    Boudet, F
    Lasarte, JJ
    Sarobe, P
    BorrasCuesta, F
    Theze, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (18) : 1671 - 1679
  • [49] A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades
    Gorny, MK
    Mascola, JR
    Israel, ZR
    VanCott, TC
    Williams, C
    Balfe, P
    Hioe, C
    Brodine, S
    Burda, S
    Zolla-Pazner, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 213 - 221
  • [50] RELATIONSHIP OF HIV-1 ENV V2 AND V3 SEQUENCES TO THE VIRAL PHENOTYPE
    YOSHIMURA, K
    MATSUSHITA, S
    HAYASHI, A
    TAKATSUKI, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S110 - S110